First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 167.47 USD -0.2% Market Closed
Updated: Apr 25, 2024

Abbvie Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Interest Income Expense Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$1B
CAGR 3-Years
28%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.6B
CAGR 3-Years
-38%
CAGR 5-Years
-27%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$172.2m
CAGR 3-Years
7%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Seagen Inc
NASDAQ:SGEN
Interest Income Expense
$51.7m
CAGR 3-Years
-14%
CAGR 5-Years
22%
CAGR 10-Years
63%

See Also

What is Abbvie Inc's Interest Income Expense?
Interest Income Expense
-1.8B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Interest Income Expense amounts to -1.8B USD.

What is Abbvie Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-19%

Over the last year, the Interest Income Expense growth was 17%. The average annual Interest Income Expense growth rates for Abbvie Inc have been 8% over the past three years , -7% over the past five years , and -19% over the past ten years .